We Called this ASX Bottom: The Next Move is Even Better

In tonight’s Australian Stock Market Show, Filip, Janine, and Zoran break down what could drive the next move. Healthcare stocks could lead the way, so where could their share prices could go next?

• 0:01Speaker 00

  This podcast is brought to you by Wealth Within, a global leader in stock market education. For more information on our courses, head over to wealthwithin.com.au. Please note that the information in this podcast should not be considered personal financial advice. Enjoy.

• 0:16Speaker 01

  The ASX healthcare sector is up 30% since June, but could the best opportunity still be ahead? New developments are changing the outlook and tonight, we're breaking down what could drive the next move, which healthcare stocks could lead the way and where their share prices could go. At Wealth Within, we go beyond market commentary. For decades, we've helped Australians build the skills to understand and trade the market through our accredited education. I'm Philip Lottefsky and alongside me tonight are senior analysts Janine Cox and Blueberry Markets Zoran Krezovic. Good evening.

• 0:50Speaker 02

  Good evening. How are you?

• 0:52Speaker 01

  Very good. Nice to have you both on.

• 0:53Speaker 02

  Good to be on.

• 0:54Speaker 01

  Yes, big show, healthcare.

• 0:55Speaker 02

  Exciting stocks, lots of variety.

• 0:58Speaker 01

  Yes, Zoran, we're going to get some FX information from you as well, so stay tuned. But let's dive right in now. Two months ago, we did a show titled Inside the Most Unloved Sector on the ASX. We were talking about healthcare, which was in freefall at the time. Now, before we tell you what comes next, I want to show you what we said on that show.

• 1:17Speaker 02

  Healthcare, it's all about healthcare, isn't it? And we've seen the US healthcare sector take off and ours usually follows.

• 1:23Speaker 03

  Also, we have Australians aged 85 and over, which are expected to double over 1 million by 2042. So this allows a long runway for the healthcare sector to really thrive for the next 10, 20 years.

• 1:39Speaker 02

  I mean, just looking at what the potential upside could be, if we can see up here around 180, I would say is a potential for CSL. And I'm just going to grab my tool there so I can, if it behaves itself. And it's up around 50% is a potential from that point there. So a pullback down closer to $105 would be a really nice little move and a push up from that, I'd like to see. Price pattern and time, having all of those things lined up increases your probability of these major turns, providing the best opportunities. So, and looking at it right now, it's looking pretty good.

• 2:17Speaker 01

  Yeah, we're going to show you the chart of CSL in a second to show you how exact Janine's prediction was. But the question now is, where to next after such a stellar rise? What's changed over the last two months and what could drive the next leg higher, Janine?

• 2:31Speaker 02

  Interesting.

• 2:32Speaker 01

  Great call, by the way. You literally nailed the pullback and the rise.

• 2:35Speaker 02

  Oh, thank you very much. I appreciate that. One important change is that we've now had August company results. ResMed reported full year revenue growth of 10%, while ProMedicus increased its underlying net profit by just over 24%. So we have evidence of growth in those businesses, not just hopes that conditions might improve. Now, for me, the interesting question is whether that growth can continue and whether the share price already reflects it. A company can deliver a good result and still be too expensive. Equally, a company doesn't necessarily need a spectacular result to become interesting when expectations are low.

• 3:14Speaker 01

  There is also evidence that investors are becoming less bearish on healthcare globally. S&P Global's report, published 21 August, identified healthcare amongst the sectors with the largest monthly declines in global short interest, which are positions taken to profit from falling prices. However, one headwind which seems to be persistent right now is the Australian dollar. It's been rising strongly over the last couple of months and does impact many of our ASX healthcare companies that are doing business in US dollars. A move down further strengthens the healthcare surge. So what's the chance we see a reversal in the Aussie dollar soon, Zoran?

• 3:49Speaker 04

  It's got a strong uptrend at the moment.

• 3:52Speaker 01

  Hasn't it?

• 3:53Speaker 04

  Yeah, has been for like three months or so. And it's probably one of the best currency, performing currency pairs in G10. When you have a look at all the major currencies versus the US dollar, I think it's, what's backing it as well is commodities, which are doing quite well. So we've got copper, we've got gold, we've got other assets that are kind of supporting that and also central, central bank policies. So Reserve Bank of Australia, because market is kind of starting to price in that will get additional 25 basis point interest rate hike coming on 29th of September. So I think all this is kind of supporting Aussie to continue heading higher. And if that is the case, then perhaps maybe some of those companies can actually continue winning on the back of that.

• 4:38Speaker 01

  Yeah, fantastic. All right. Well, let's get into the fun stuff. Janine, stocks.

• 4:41Speaker 02

  All right, shall we? CSL is the first one. So a lot of people have been excited about what CSL has done recently. Stronger plasma medicine sales and restructuring savings need to translate into higher profits. The key catalyst would be evidence that the earnings recovery is accelerating with business growth, not just cost cutting, supporting a stronger outlook. Isn't it always that people are talking about cost cutting and then you see the share price language, language for ages? And we really need to see some growth, don't we?

• 5:11Speaker 01

  Yeah, but for me, the more interesting thing was, you know, what you called two months ago, where it was sitting was a few weeks up. You specifically said a move down to 105 and then up to 118. You know, I'm pretty sure, knowing you, that's not just a random comment, you know, that's very specific.

• 5:31Speaker 02

  You know how much effort goes into determining where these turns are. It's not just drawing a couple of lines on a chart, it's actually doing the full suite of analysis, which we're pretty open about it. I mean, we teach it to, to anybody who really wants to learn so that it's not a secret, but it does take time and a technique to, to get that right. And once you have it, you've got that skill for life.

• 5:54Speaker 01

  Yeah. And if you do want to learn how to do that stuff, check this book out, How to Beat the Managed Funds by 20%. It is free, you just have to pay the shipping. The link is in the description below. Otherwise, if you do want to take things to the professional level, make calls just like Janine's done, just like we've made for years on this show, and really take control of your trading. Go and visit the website, wealthwithin.com.au, look at our accredited share trading diploma, and please check some of those testimonials out to see what is possible, so that you can take, really take control in this beautiful time in the markets. But back to CSL.

• 6:26Speaker 02

  Yeah.

• 6:27Speaker 01

  You made the first call. Where to now?

• 6:28Speaker 02

  Well, look, you know, do you think I can get two out of two? That's the question, isn't it?

• 6:34Speaker 01

  I think so.

• 6:35Speaker 02

  So, so right now, we're looking at a consolidation. Now, when a stock slows down like this, it's usually because price is likely to slip away. But, but the sellers are not giving up on it. It's just hanging in there, which is quite incredible. I would expect it to come back a little bit, not far, maybe into the low 60s at the most, and then start to move back up and push up towards 100. But I don't see it going too strongly further forward at this time, because let's face it, this was results reporting season.

• 7:05Speaker 01

  It's over.

• 7:06Speaker 02

  So I'm not saying that we're going to see another big rise like the one that we've just seen now. I still think it could drift higher through the 200s, but whoever's made a lot of money right now would be pretty happy with themselves.

• 7:17Speaker 01

  Well, that's normal, isn't it? I mean, you get reporting season and then after reporting season, the big jumps, they start to settle down.

• 7:23Speaker 02

  Yeah. So then the money tries to, you know, there's a bit of a profit taking, a pullback, then the smart people try to come in again and get that last run up. But this is where the danger is though for FOMO, for people who have been, who have missed out on this run. If you don't have that skill to manage your exit and the stop loss properly, that's where you can see other people who have just made lots of money and then you could get caught short.

• 7:45Speaker 01

  Yeah, yeah, it's all about keeping it. So let's move on to our next stock now, Zoran, PME, I believe.

• 7:51Speaker 04

  Yes, the next stock that we have is PME, ProMedicus. More US hospital contracts and a full year of revenue from recent installations could drive the next earnings lift. The key is converting its expanding customer base into continued strong profit growth. So I think this is an important one that we discussed or mentioned just previously, where Aussie dollar has a lot of exposure. And if the Aussie dollar is actually gaining kind of momentum and doing quite well, then hopefully what it can do is help with regards to, you

• 8:33Speaker 04

  know, these companies like such these, they have US exposure. So I think overall, it's still looking quite bullish. My only concern at the moment is that it's actually created a lower high here and hasn't broken the prior high, which is around $218. Nevertheless, there is a bit of a gap here on weekly chart, which is around $137. So if you do take the low of 155, which was created on 24th of July 2026, we would technically break this downtrend. And obviously, we would expect the price to actually come down and hover around 130 to 140. So that's kind of my base case for, for the price to continue heading

• 9:15Speaker 04

  lower and close the gap. And then if you can find ground within the range of maybe 110 to 130 and start heading higher, then hopefully there is a bit of momentum for that to actually continue heading up.

• 9:28Speaker 01

  It's really interesting when you look at stocks like this. I mean, coming off major lows, I think the big question for, for a lot of investors, even, even traders, new traders is, am I buying a correction or am I buying a serious low? And that's, I think, the big distinction that, that is so important when you're trading stocks like this in the healthcare sector, because you're not trading full blown trends, you're trading, in my opinion, somewhat of the riskier type scenarios, but probably the better risk reward scenario. So would you say this one's more likely that it's turned the corner or still a bit early for you?

• 10:01Speaker 04

  Yeah. If I compare this one to CSL, I'd probably say CSL might be a little bit overdone. And like Janine said, I would expect like a small percentage pullback. And it's still got that, you know, creating high highs and higher lows. So it's, it's in a clear uptrend still, and the volume is supporting the move. But if I have a look at this one, this one might be like changing its trend and it might be actually heading lower. So if I compare the two, I'd probably go with CSL at the moment, but I would actually wait patiently for this one, do some key levels on the chart and wait for the pullback. And once it's ready, get in.

• 11:01Speaker 01

  All right, well, let's get to the third stock.

• 11:03Speaker 02

  All right, and it's Cochlear, so another good one, which is interesting. So if we have a look at what's going on and we run a bit of a line under here, we can see that we'd said in another show that Cochlear would come back here and turn.

• 11:18Speaker 01

  There was another one.

• 11:18Speaker 02

  And you may have even said that yourself. And it has done that and gone up to about 140, which is interesting now. It's really going sideways at this point. I was talking to one of our clients who's a mentor. He's gone through and done both courses and he's looking at Cochlear. And we're just looking at the fact that it's at a really important level at the moment. It's trying to pull back, hasn't done it yet. I still think it will, so I'd be waiting for that pullback for it to. But there's still upside with this one. This is the thing, there's still opportunities with Cochlear to get in. Obviously, the best opportunity was at the bottom. We can see that with the benefit of hindsight, but there's still time there.

• 12:02Speaker 02

  We know that through our time analysis, but and there's also upside potential because we can see that the angle of that trend hasn't been touched yet. It's not even gone to that point yet. So what can happen sometimes, though, is that stocks can pull back and you've got to do your full analysis to see how far it could come back. But Cochlear could even come back somewhere into this zone before it then takes up to that point. So there's a number of ways that Cochlear could unfold at the moment. It's not as, I wasn't as confident on this one as I was on CSL. So you can see that that's one possibility, but I'd just watch it and see if it actually does unfold like this in a proper fashion.

• 12:42Speaker 02

  That would bring Cochlear up around the 180 mark to meet the angle of that line.

• 12:48Speaker 01

  Yeah, but to me, this is a perfect example of why you need to be looking at price and have a skill set to be able to trade a stock on knowing the when, not just the what. Because in August, which has just passed, you look at where the share price is. And like you said earlier, the best opportunity to make the best profit out of this stock was back, you know, as it was reversing on that really important level.

• 13:14Speaker 02

  Bottom down there, yeah.

• 13:15Speaker 01

  And at that time, the news was terrible about the stock. And so, you know, I hate hearing this comparison, oh, well, you know, the story, the story, the story. Well, 99% of the time, you're going to hear the story after the best move. And the ones that are watching price are going to make the money before you even think about getting into the stock. And you might be the sucker getting into the FOMO. And so, another example.

• 13:38Speaker 04

  I think you raised a great point because I think Cochlear did have really good results in terms of the reporting now, but the move was already actually there, like you mentioned. So, I mean, you know, we do learn and you guys do teach in the course that you don't need to worry about the bottom 20% and the top 20%. What you need to worry about is the middle 60%, right? Because we can never pick the bottom, right? Like some people would have maybe considered this was bottom at the time. And hindsight is a 2020 vision and it's hard, but there was an entry here as well.

• 14:09Speaker 01

  That's not hindsight to me.

• 14:10Speaker 02

  Well, some of our, some of our students bought there.

• 14:13Speaker 01

  Yeah, that have bought that and made money, real money.

• 14:16Speaker 04

  I mean, I'm a little bit conservative. So for me, the real move on this one was actually when it broke out of that high here, which was around 131, and this was in August. So I still think this move is actually imminent and I still think it's valid. And it could continue heading higher as long as you have the set rules. There's nothing to say that it's not going to go up to $160, $180.

• 14:41Speaker 01

  Well, that's a beautiful thing. It's not only one entry, you can get in any point.

• 14:44Speaker 02

  Look at that monthly chart, it went straight up, didn't it? It still has to pull back at some point and then produce another opportunity.

• 14:50Speaker 01

  Which is again, another thing, what's your strategy? Are you short term, are you medium term, long term? A short term trader's already in, a medium term trader's looking like you're looking, a long term trader's not in yet. Each of those can make money, depending on when they get in.

• 15:03Speaker 04

  There's no right or wrong.

• 15:03Speaker 01

  You know, the only last thing on that chart which really caught my attention was that volume last week. What do you make of that? Biggest volume, I think.

• 15:12Speaker 02

  Someone's sold off the stock. Someone's traded their position.

• 15:16Speaker 01

  Because if you zoom it out, I think that volume, weekly volume there that we've had last week was probably the biggest volume we've seen.

• 15:22Speaker 04

  I think that was subject to the reporting season and the results coming out. I think there was a, we'll back that up. Because what we've seen is in this reporting season right now on ASX, 51% of the stocks actually moved up 5% or more post the results that came out. So that move, I would say, was probably subject to higher, more than 5%, which was probably more of an emotional play than anything else.

• 15:53Speaker 01

  Yeah, look at that, most weekly volume ever.

• 15:57Speaker 02

  Yeah.

• 15:59Speaker 04

  Cheap.

• 16:01Speaker 01

  One to watch for sure. All right, well, stick around because we've got more amazing stocks to show you. And we've got a very special giveaway tonight. We are giving away 20 tickets to the 15th Annual Microcap Conference here in Melbourne, which will be held on the 20th of October. If you want to attend the conference for free, email through your full name to [email protected] and we will get in touch if you're a winner. Those tickets are not cheap and you could find the next big hot stock or small microcap stock at that conference. I know we've seen plenty over the years, but now let's move on to our trending topic. Janine, what have you got?

• 16:35Speaker 02

  All right, so we've looked at ANZ a few times on the show to give you the best times to buy. And with ANZ taking the next step in bringing Suncorp Bank under its name, there could be another one. Will a bigger bank mean better returns still to come? And what's changing? Well, ANZ completed the acquisition of the banking arm of Suncorp in July 2024. Now they've got to bring the two banks together. Suncorp Bank customers will be moved on to ANZ's banking system services and digital platforms by June 2027, which could be in the nick of time. There's a storm brewing that will send shockwaves through our financial system. To the CEO Nuno Matos and his team, you'd better get this right.

• 17:21Speaker 02

  So what's the payoff? It's a big one, at around $500 million in annual savings, with the full benefit expected in financial year 2029. Now, by my calculations, our market will have crashed by then. So the savings could be right on cue to help ANZ weather the storm. My only concern is that ANZ has in the past tried to pull off some pretty big changes when the timing wasn't right, which held the bank back for years. Now, in August, ANZ said its Suncorp integration was on track to meet its financial year end milestone. That gets a tick. The group's on track, having reported cash profit of $1.9 billion

• 18:05Speaker 02

  for the June quarter, up 1% on its average quarterly profit in the first half. Tick. Now, even if the deal delivers everything ANZ expect, how much of that success are you already paying for in the share price? Don't buy based on story, so let's take a look at the chart.

• 18:25Speaker 02

  So here's the chart of ANZ, and we should actually go back and have a look in history just to get a picture of where ANZ is in the scheme of things. Now, if we put a line across these tops here and bring that down just to keep it simple, we can see there that there is some serious resistance and support at this level now. Now, this is the first time that ANZ has broken through this $32, $33 mark. It's come back to test that, but the test is not over yet. So the market's obviously hanging out to see what ANZ can do. It's possible that ANZ could come back and test that level a second time. So we've got to watch for that.

• 19:08Speaker 02

  But I think that ANZ could be the next $50 stock. That's what I'm saying for ANZ. And I just think that it's timing here we're waiting for. So price, time and pattern have to meet. We need ANZ to actually fully flesh out that level and then turn around and start heading back up. Somewhere up around this area up here, could be $47, $50, we'd see ANZ peak out. And that, I think, will be the top for ANZ before the crunch.

• 19:39Speaker 01

  Yeah, right. Big call.

• 19:41Speaker 02

  Big call, relying on them to deliver and keep ticking those boxes. If they continue to do that, then we could see ANZ up around those levels.

• 19:49Speaker 01

  Awesome stuff. All right, well, if you want the skills to analyze stocks, just like you've seen tonight, visit our website, wealthwithin.com.au. But let's get back to our topic and some more healthcare stocks. Zoran, what have you got?

• 20:01Speaker 04

  We've got TLX.

• 20:04Speaker 04

  FDA approval of PEX CLARA with a decision target of on 11th of September. Could open another revenue stream, but approval is not guaranteed. Continued growth in eloxic and guzilic sales will strengthen the existing business. Geez, I got out of that one.

• 20:25Speaker 01

  Well, that'll be September soon.

• 20:26Speaker 04

  Yeah.

• 20:27Speaker 01

  Couple of days.

• 20:27Speaker 04

  So that's actually over the next couple of days, right? What a milestone date, September 11. The chart looks actually pretty good. I actually really like it, especially on weekly chart. My only concern right now is that volume is kind of trending down. It's not being overly too bullish. I'd prefer to see something like what we saw at the bottom here when the volume was increasing. But the move up and then, you know, retracement prior to the next leg higher looks actually pretty, pretty good in my eyes. So I'd be probably looking at a support level or a resistance level around $17.60, closer to $18.

• 21:09Speaker 04

  And then my next leg actually would be probably somewhere around these levels, so $14. So even if you do hover around these levels and actually find better support or sideways movement, that's fine, I wouldn't be too concerned. The low of $8.76 all the way up, the trend is still actually fully in play, uptrend. So hopefully there is enough momentum and volume to support that move. And the announcement is positive on the 11th of September. And, you know, it can push the price higher because if you do break above $18.30, which is the high on 21st of August, then I think we can easily go to $20.22.

• 21:50Speaker 01

  Yeah, all I'm going to say is if there's any of our students watching, go back over module five and have a look at what's happening on that chart right now.

• 21:57Speaker 04

  Yeah.

• 21:58Speaker 01

  Because that might tell you exactly what's about to come next.

• 22:01Speaker 04

  Yeah, there's some stuff for Advanced Diploma as well. I know where you're referring to.

• 22:06Speaker 01

  Can't give away too much, but yes, very interesting. All right, Tealix, watch that one and just be mindful that it is reporting FDA in a couple of days. So it may be very volatile over the next few days. Next stock, Janine.

• 22:18Speaker 02

  All right, the next one we've got is Neuron Pharmaceuticals, N E U. Now, this is incredibly volatile. I mean, we're talking about the stock that's been bouncing between $12 and $26 for quite some time. A trader's dream.

• 22:33Speaker 01

  Isn't it? Quick money.

• 22:35Speaker 02

  Okay, this is, it says, "Growing debut sales would increase royalties, while the planned German launch could generate milestone income and additional royalties. Positive Japanese trial results and progress with its next drug, N N Z 2591, are further potential catalysts." So it's got something coming up. And that's probably why it's risen so strongly just recently. But this sort of setup looks like it could be an intermediary move in that the next move up could take it to $30 or more. So that's the interesting thing about this one. Now, if we go to the weekly chart, that'll give us an idea of what's going on more shorter term. A pullback's underway.

• 23:18Speaker 02

  There's a little gap down here, which would be a little bit of a concern in the short term. And it's got a huge resistance level here. It needs to come down, find support somewhere between $18 and $20, which it's doing. But then it's got to make the move through 24 now. I would not be trying to pick this up at this point right now, given that that gap's there, given the resistance that's there, until it shows some momentum in the direction of where we want it to go again. If you haven't already got it, if you've got it, fantastic, I would stay with it.

• 23:51Speaker 01

  Yep, awesome.

• 23:53Speaker 04

  There's also a gap here as well. I'm not quite sure whether that's been filled, but let's have a look.

• 24:00Speaker 02

  I'm trying to be precise there, I wouldn't be, not with these sort of stocks.

• 24:03Speaker 04

  Because I think, I think Mark actually attempted to close it here, but he didn't. So just a bit of a warning.

• 24:11Speaker 01

  But I think, you know, it's interesting that you point that out because also I think with these kinds of stocks, you mentioned the right word before, trader stock. Because really, these stocks are driven by momentum. Where the real power is, and it's just my opinion, but if you guys agree, that working on a technical lens with these stocks, following, catching those runs is where the real, you know, power is in this. It's not sitting in it and going, oh, well, I'm going to hold, I'm going to wait for the next catalyst. I'm going to look at it long term from the point of view of saying, well, I think it's going to drop another 80% before I look at it again. You're going to miss years of great runs and good opportunity.

• 24:49Speaker 04

  Yep.

• 24:51Speaker 02

  Actually, a really good study would be just plotting the announcements on the chart and having a look at what came out when and just to see exactly what you're saying.

• 25:00Speaker 01

  Yeah.

• 25:00Speaker 02

  How getting in, and you can see it on the chart here, just on these bottoms here, there were times to get in when the stock turned, as Phil's talking about, which if you wait for the announcement, which may have been this, you know, there was an entry in here. If you waited for the announcement, you would have been sitting in there with a pullback, but all of a sudden it would have taken off for you. So there's probably heaps of examples over the history of it like that.

• 25:25Speaker 01

  Yeah, yeah, fantastic. All right, Janine, I know you really wanted to give the viewers this stock. It was just a little specky, which I don't know if I have to check your temperature on going to the specky world.

• 25:35Speaker 04

  What's happened there? I thought there was like a $1 club.

• 25:38Speaker 02

  Yeah, $1 club. Noxo Farm Limited is a clinical stage Australian biotech company discovering and developing novel treatments for cancer and inflammation, including pioneering technology to improve the safety profile of a range of mRNA medicines. Now, this is all crucial development. What I think's really interesting is just the setup. And all the time we're looking for these sorts of things on a chart to see whether we get the same sort of patterns forming. We expect stocks to do what this stock has done. You know, this is the interesting thing about it. And we do like to see these basing out patterns occur because these are the sort of patterns that can give a really nice setup.

• 26:22Speaker 02

  I'm not talking about trying to pick this at a low. We are talking about a 10 cent, you know, 7 cent stock.

• 26:28Speaker 01

  Yeah.

• 26:29Speaker 02

  So therefore, you've got to pick when that opportunity is. We can see how fast it actually goes. This is a monthly chart. If I change this to a weekly chart, you can see the volatility of this. But, you know, being able to get in at the right time, there was no real entry there, you know, proper entry there for you. But even if you did pick a particular type of entry that could be classed as a reason to get in with the reversals included, there was an incredible return there. So I'm just going to have a look at an example and say, look, you know, in literally a couple of weeks, a 70% profit. Now, notice how the stock consolidated here after the low. There would have been opportunities there as well.

• 27:13Speaker 02

  So it went up and ultimately about 80% coming off that bottom there. And the same here, if you can, if you've got rules that you can get in and get out, the key is, do you stay in? You know, when, especially now when you're seeing this sideways move unfold. And what's interesting to me is the runs up are getting lower, but the runs down are getting lower as well. Shorter, so therefore, you know, if you're able to get in at this opportunity and we go up another 80%, we could be talking 18 cents or 20 cents as a possibility to start if this thing turns around and goes through those highs.

• 27:49Speaker 01

  Yeah, I'm glad you picked this stock up because I know we, a lot of the time we look at big stocks only and, you know, there is reason for that. But we have a lot of people that trade small cap stocks like this.

• 28:00Speaker 02

  That's right, and we're going to the micro cap conference.

• 28:02Speaker 01

  We're going to the micro cap conference. So if you think our stuff is only for big cap stocks, think again, we have a lot of people that play the small cap market. And the techniques and skills that you'll learn in the book and the course can allow you to trade any market, whether it's commodities, futures, stocks, you name it. Crypto, just know that because I know, you know, sometimes we get pigeonholed in this big stocks only and that's not what it is. I know all of us trade different areas of the market and price is price regardless. It's just knowing what risk you're willing to take. So Knox is setting up interestingly.

• 28:38Speaker 02

  Well, look, we've seen it go down for a couple of weeks, which is not what we're wanting to see. We're wanting to see it move up through and make new highs. But quite often, stocks will come back and test. We can see the strength of the level underneath all that. And there are, you know, some really good support there. So if it comes back, test support, would it have to come back that far? Possibly not, let's just have a look. There's probably a reason that it's going to, it could have support right here. So if it does and turns around from there, I think that could be quite interesting.

• 29:09Speaker 01

  Awesome.

• 29:10Speaker 04

  From my point of view, I would just backtest the moves on the upside, what Janine actually showed on the chart and see whether there were any announcements that impacted such a large and aggressive moves.

• 29:23Speaker 01

  Awesome. All right, Zoran, you got the last one, mate, Sonic.

• 29:26Speaker 04

  Sonic, good old Sonic, yeah. So Sonic Healthcare, Sonic needs growing testing revenue, cost savings and acquisition benefits to lift profitability, better US laboratory performance and further integration savings in Germany and Switzerland could provide evidence that earning growth can continue. One of those stocks that hasn't unfortunately done so well in the healthcare sector and probably one of the few that's been actually kind of trending down at the moment. The volume does actually indicate there was something major that happened. Not quite sure whether it was, you know, the earning results in the August earnings season, but it absolutely got slaughtered.

• 30:10Speaker 04

  So from price point, price percentage point, this was a massive drop of 23% on such a large stock. We've actually seen something very similar in the past as well. Aggressive moves to the downside, but I'm not discounting the fact that it could actually provide better support here around $18. If it doesn't and it breaks the major low of $18.26, then I'd be probably starting to look at the chart on monthly and I'd be looking for some key support levels, which could be a little bit further down. So, I mean, right now, it's not looking good. This one is definitely on the list that I'd be probably be quite patient and watch closely.

• 30:54Speaker 04

  You would need to find good support base before you actually start standing around and heading higher because it is a bit of a falling knife. If you're short selling it, it could potentially work in your favor.

• 31:04Speaker 01

  Opportunity, all right. Now, before we move on, I'm guessing that's not your favorite. What's your favorite pick of the bunch?

• 31:09Speaker 04

  Well.

• 31:11Speaker 04

  I'd probably go, let me just have a look. I'll probably go with this one. I'll go with Dalex Pharmaceuticals. I'll go with that one just because it looks fairly safe at the moment.

• 31:25Speaker 01

  Yep, Janine?

• 31:26Speaker 02

  Yeah, Dalex looks good as well. I probably would have to go with a big one and given this you're going with it. So I would say let's go with Cochlea and wait for the pullback.

• 31:39Speaker 01

  Awesome. Excellent stuff. All right, guys, moving on shortly, we're going to get into our hot stock tip. But first, let's answer your questions.

• 31:47Speaker 05

  Hey, podcasters. Are you trading the share market but want to take your knowledge to another level? Dale's award-winning book, Accelerate Your Wealth, will get you there. Learn to master the stock market with trading strategies that will exceed your expectations. Secure your copy now by visiting the shop on the Wealth Within website.

• 32:10Speaker 01

  Leanna writes, I shorted the stock Dow or D O W at $7.66 on the 12th of August. I'm looking to pull some profit out at $6 and have moved my stop loss to 6.92. What do you think of this trade now? I love the fact that you're talking about shorting. So well done on that. And I'm going to go to Janine on this one.

• 32:30Speaker 02

  Yeah, was it 6.92 was the stop loss, was it?

• 32:33Speaker 01

  I believe so.

• 32:35Speaker 02

  Okay, so that means that

• 32:36Speaker 01

  That's the entry.

• 32:37Speaker 02

  That means they could be out, is that right? So 6.90, it's fallen through that. Is that what we're talking about here? Because it's

• 32:44Speaker 01

  Yeah, I believe so, trailing stop.

• 32:46Speaker 02

  Yeah, so it's actually gone through that point already. But maybe they're still in it.

• 32:52Speaker 02

  And they're not understanding the stop losses and how they work. That's a possibility as well.

• 32:57Speaker 01

  Or she sent it in before, last week, before this week's unfolded potentially, but

• 33:03Speaker 02

  But look at the angle of that. So there was a probability that it was going to come back to the angle of that anyway. So if she's still in it and then saying, well, okay, if it starts moving up, then I would set the stop loss here. But maybe that's because of this high here. I don't know what the reason for that is. It doesn't quite make sense unless it's a percentage stop that's being used. But I think the more interesting discussion here is about where was the entry?

• 33:31Speaker 02

  What was the entry price? Have you got that there for me? I think it was $6, was it? Because if she's got in over here somewhere, then, you know, that's

• 33:41Speaker 01

  7.66.

• 33:43Speaker 02

  7.66, so it's up here, right at the high, pretty much.

• 33:46Speaker 01

  On the 12th of August, so back

• 33:49Speaker 02

  Just here?

• 33:50Speaker 04

  Well, I think that's actually a good entry, though.

• 33:52Speaker 01

  Yeah, it's awesome.

• 33:53Speaker 02

  I'd quit, well, I would question that, so 7.66.

• 33:56Speaker 04

  No, no, but in August, in August.

• 33:58Speaker 02

  August?

• 33:58Speaker 01

  That way, yeah.

• 33:59Speaker 02

  There?

• 34:00Speaker 01

  Yeah.

• 34:00Speaker 02

  Okay, so we're shorting, aren't we?

• 34:02Speaker 01

  We're shorting.

• 34:02Speaker 04

  Yes, I think that's a great

• 34:03Speaker 02

  Okay, yeah, fantastic. So in terms of the line, you know that it's more likely to come back at some point. It's probably, there's probably the angle of the trends up there or even there. It's underneath that line now. And yeah, beautiful. But in terms of a stop loss, this is where the challenge is, isn't it? Because it could just come straight through it. It may have already been, you know, it's not quite there. But look, you know, it's really close to that stop loss. Is that a good place for the stop loss? That's really the question, isn't it?

• 34:32Speaker 01

  It's almost, I think she's trailing it on the way down, almost like a take profit.

• 34:35Speaker 04

  Correct.

• 34:36Speaker 01

  And yeah, I don't know.

• 34:38Speaker 02

  I don't have any issue with it.

• 34:39Speaker 04

  Did we, so let's just go back. I like this. I think she's done a great job. What was the, Leanna? Yeah, well done. I, let me just have a look at the price percentage tool, so.

• 34:51Speaker 02

  Yeah, it's the right volatility, isn't it, that stock?

• 34:55Speaker 04

  I mean, I can't give away too much, yeah.

• 34:58Speaker 01

  No.

• 34:58Speaker 04

  Provide personal advice, but like, there's different ways to trail it because it's a falling knife. And even if it comes back up, you want to give her enough room in case it turns around and creates a lower high and continues heading lower. That's something just to consider. But I think the entry is actually pinpointed perfectly. I think trailing stop loss is the way to go, just in case you want to lock in some profit. It's just how you manage it now and make sure that you don't cut your profits too early.

• 35:26Speaker 01

  And you cover because there's a reason to cover. And there are a lot of reasons on that chart I can see that could mean this stock's about to reverse up. So, yeah, I think well done. I mean, I don't know if you're a student or not, but super job. Well done, Leanna. Let's move on. Henry's email is next. I'm trying to diversify my trading skills and I've recently started looking into shorting stocks. Another one, jeez, we must be rubbing off on people.

• 35:50Speaker 04

  Hopefully they're doing it with Bloomberg.

• 35:51Speaker 01

  I read an article saying Drone Shield is currently the most shorted stock on the ASX with around 15% of its shares shorted. Do you think the level of short interest is justified? And is this a sign that Drone Shield could have further to fall? Or do you think the market may be overreacting, creating an opportunity for a potential rebound? Well, I mean, it's always interesting when someone asks, do you think it's justified? It's happening. So your job as a trader is not to work out, is it justified or not? It's to say, okay, this is happening. How do I make money from this scenario?

• 36:23Speaker 04

  That's a good point. Another good point, I think, is to raise questions around where do you get factual information? That it's the most shorted stock on the ASX and what does it mean for you as a trader?

• 36:34Speaker 01

  Yeah.

• 36:36Speaker 04

  Because, I mean, people go short long, they change their positions, fund managers do all the time. So one day it might be the most shorted stock, next day their view might change. Now, is it just because they actually want the retail crowd to come in and basically follow their path?

• 36:53Speaker 01

  Or there's a lot of also, it's not a directional thing. It could be hedging, it could be a whole bunch of other reasons why it's happening.

• 37:01Speaker 04

  Heaps of people do hedging. I know people with us do tunnel hedging as well, especially around key levels, support resistance levels.

• 37:08Speaker 01

  Yeah.

• 37:08Speaker 04

  Yeah.

• 37:09Speaker 01

  So when you look at the chart of Drone Shield, it's been hammered. I mean, they had some problems with the CEO. And it was crazy, the timing of it happening. I mean, they were printing record contracts or winning record contracts. And then the CEO, don't quote me, I can't remember if he resigned or something happened. But the share price has been pumped from 4 bucks.

• 37:32Speaker 04

  So what was the level that he entered, did he say?

• 37:34Speaker 01

  No, he hasn't bought it. He's just wondering why it's shorted so much and could reverse.

• 37:39Speaker 04

  I mean, yeah, of course it could reverse, but like, everything is pointing towards downside at the moment. And you know what, like, the volumes are actually increasing as well. If you have looked at over the past few weeks, we are seeing some sort of consolidation here. But obviously, the low here, 165 is the key. Because that's actually been a good support level back in November 2025, before the next leg higher up. So, I mean, for me personally, I would need to see this stock between 150 and 160 to consolidate, even if it goes a little bit lower, to actually find some sort of base and retracement or solid foundation here. And then hopefully it can actually trigger more volume and confidence for buyers to come in and start trading higher up.

• 38:24Speaker 04

  Because at the moment, it's looking, everything is pointing towards downside. Like, it's looking super bearish right now. Like, I mean, it's hard to be a bull on a stock like this at the moment for me.

• 38:37Speaker 01

  Yeah, I think the bigger question is, how good are you? Or what skill set do you have in being able to identify, could this be the bottom? Because there's two questions you need to ask as a trader. The first question is, is there a reason this stock could bounce from here? I would say potentially, if you know what you're looking for, and we're not going to get into it. How do I confirm that that's happening and where is my trade? That's the second question.

• 39:03Speaker 04

  Yeah. Well, it comes to your speculation and confirmation, right?

• 39:06Speaker 01

  That's right.

• 39:07Speaker 04

  Do you speculate to trade or do you actually use rules and tick them off based on your trading plan? And having a set of rules that you confirm and tick before you actually enter that trade? That's one thing that I got taught by Janine.

• 39:21Speaker 01

  Janine, yeah, well, she's taught you well. That's great advice. All right, thank you, Henry. Hopefully that helps. Good place to be looking, but some more confirmation needed now. Jason is next and writes, it's been a while since I've invested. And in the past, when I have invested, I've tried to be really cautious and apply a stop loss. But I've never made profit on any stock. I haven't done your education, but I've been considering it. Well, you know, I recently found 1500 left in my Comsec account. And I purchased three stocks, Northern Star, Treasury, Wines and Zero. Can you pick a stock to look at and let me know your thoughts? Now, we've chosen Northern Star, we can't do all three, unfortunately.

• 40:00Speaker 04

  Yeah, that stock is done.

• 40:02Speaker 01

  But, but, you know, having struggles, never having success or never being, you know, having and then still going again and again and expecting the same result?

• 40:16Speaker 02

  I would have just saved up to do our trading mentor course a little bit more, rather than put the money into stocks. Because that amount of money is really not going to make you anything. By the time you pay for the brokerage and everything else, it's more at a training level. You know, that sort of dollar amount would be for where you know you're not going to lose anything. You're not really going to make much. But, you know, I don't have any issue with the stock that you bought at all. Northern Star, I think, is a good, good stock. It's just a question of how high will it go now and what's the stop loss really? And I mean, if Northern Star goes back below around 1950 or round about there, $20, then it's probably going down back to the angle of that trend.

• 40:59Speaker 02

  That's, you know, as simple as I would put it. If it goes back above your buy price strongly over the next few weeks, then we could see it head closer to 28, 29. In the short term, but really that physician size, you know.

• 41:14Speaker 01

  Well, I don't want to be harsh or anything, but I'm not sure if he would even understand any of this, that the advice that you're giving. And the second thing is to follow it because if you've experienced only bad experiences in the market and you're repeatedly doing the same thing, you bought three stocks just because you've got money in your account. How can you expect a different scenario?

• 41:37Speaker 02

  Yeah.

• 41:37Speaker 01

  This advice, how's it going to help you?

• 41:40Speaker 02

  Yeah, there's a saying for that too.

• 41:42Speaker 04

  Yeah. I think the positive is he hasn't gone with speculative stocks, if I can say it that way at least.

• 41:47Speaker 02

  Yeah, I think that's.

• 41:48Speaker 04

  He could have gone way worse. I mean, Northern Star is a top wind stock.

• 41:53Speaker 01

  Regardless, irrespective.

• 41:54Speaker 04

  I know, but I'm trying to play devil's advocate and get some positives out of here. But I think contrary to that, the negative is obviously, Jason, that, you know, not having appropriate stop losses could come down to your education and knowledge. And as a result of that, maybe some of those trades in the past could have been the winning trades, but because the correct set of rules hasn't been applied, as a result, you actually got a loss or slight profit, if I can that way. And I'm always like, you know, yeah, education is a big part because like I'm working for a broker and I see on daily basis, people generally want the shortcuts, which might work in the interim and on short-term

• 42:38Speaker 04

  basis, but longevity in the long term, if you want to play the financial markets, it will actually beat you to it. It will, it will, it will always punish you. So do you want to protect yourself and pay maybe a little bit out of your comfort zone, get some money and pay for the course, get the knowledge and then hopefully utilize that knowledge to actually make up for the cost that you actually spend on or.

• 43:03Speaker 01

  Yeah.

• 43:03Speaker 04

  I mean, there's different ways to justify, I guess.

• 43:05Speaker 01

  Again, if you've got two ways to learn from the market, you can either learn by getting an education or you can let the market teach you. And the second one is not a, it's not a nice lesson.

• 43:16Speaker 04

  I mean, get a book to start off with.

• 43:17Speaker 01

  It's a harsh lesson.

• 43:18Speaker 04

  Maybe get a book and start with that and then see whether you can actually have some fundamental.

• 43:23Speaker 01

  Yeah, yeah. Hopefully take that on board, mate. Not trying to be harsh at all, but just understand the market is a much harsher teacher. But anyway, let's move on and get into something more positive. Our hot stock tip, Zoran, what have you got?

• 43:35Speaker 04

  Yeah. Today we got Santos Limited, which is looking strong fundamentally. It's increased its Papua LNG stake from 17.7 to 21%, which should lift its share price of LNG production there by around 19%, 19%. Pika is now producing oil while higher oil prices are also another tailwind. The key catalyst now is Papua LNG with a final investment decision targeted for the fourth quarter of 2026, while investors will also want to see Pika ramp smoothly.

• 44:11Speaker 04

  I think it's a good stock. I generally believe so. And I think it's done the hard yards in a lot of different ways. We always talk about making investing and trading very simple and kind of market providing us with the signal as opposed to us actually looking for these golden nuggets. I think Santos has actually got the $8 resistance level that's been playing around and trying to break for a significant period of time. Whilst it has done so on a couple of occasions, like during COVID back in 2020 and on another occasion back in 2020, hasn't closed above that resistance level. And it's every single time it's actually come back within the range. If we focus on the last major range here, we can actually

• 44:56Speaker 04

  see a major low at $5.20 in April, in April 2025. Ever since then, the stock has actually done quite well. And on the weekly chart, we can actually see that it's kind of gaining a very, very strong momentum from the lows back in June 2026. Obviously, we're seeing quite a lot of tension going on back again on the table and headline news around straight to Hormuz. Crude oil and Brent oil has been actually kind of spiking up right now. So the volatility is actually elevated. Higher prices will obviously support stocks like Santos and Woodside. So I actually think fundamentally and technically Santos is something

• 45:40Speaker 04

  that I'd be looking at. And I think it's actually got a lot more upside, at least up until $9 or so.

• 45:47Speaker 01

  Well, I think that the catalyst is changing now for this one finally. It used to be the takeover. This one, there was a takeover offer at $8 and for a long time the market was punishing it for saying, no, that's the limit that we're going to value you at. Now, like you said, this liquefied natural gas catalyst that's happening could be the new story that could finally send Santos higher.

• 46:08Speaker 00

  This podcast is brought to you by Wealth Within, a global leader in stock market education. For more information on our courses, head over to wealthwithin.com.au. Please note that the information in this podcast should not be considered personal financial advice.